Patent 2017201661

BIN1 expression as a marker of skeletal muscle mass and neurological conditions

Abstract

Attorney Docket No. 10074-002WO1 ABSTRACT Provided are methods for determining skeletal muscle mass in subject. Also provided are methods for diagnosing a neurological condition or disease or a condition or disease associated with reduced skeletal muscle mass in a subject. Further provided are purified antibodies that bind specifically to a BIN1 polypeptide that is expressed specifically in skeletal muscle. 8815279_1 (GHMatters) P93853.AU.1

Information

Australian application number
2017201661
Country
US
Status
Filed
Type
Standard
Applicant
Sarcotein Diagnostics LLC, LLC (US)
Application year
2017

International Patent Classification (IPC) codes

Links

ID Relationship
2011345312 Divisional parent